Brief: Eurocine Vaccines Q4 EPS at SEK -0.111
30/08/2023 07:31
Aug 30 (Reuters) - Eurocine Vaccines Q4 EPS SEK -0.111. * Q4 revenue SEK 0
Recent news on Nidhogg Resources Holding AB (publ)
See all newsBrief: Nidhogg Resources Holding Resolves On A Directed Set-Off Share Issue
Brief: Nidhogg Resources Holding AB Announces The Termination Of The Al Baraka Project In Egypt
Brief: Eurocine Vaccines Q4 EPS at SEK -0.111
Brief: Eurocine Vaccines Says Decides To Develop mRNA-Based Vaccine Candidate Against Chlamydia
Brief: Eurocine Vaccines Expands Its Portfolio With A Therapeutic Hsv-2 Vaccine Candidate